Researchers at Mie University in Japan have successfully used the CRISPR-Cas9 gene-editing system to excise an extra copy of chromosome 21 from human cell lines. According to the study published in PNAS Nexus, this process restored near-normal cellular function, including improved mitochondrial efficiency and faster growth rates in stem and skin cells, marking the first time a full extra chromosome has been removed from human cells.
How CRISPR-Cas9 Targets Chromosome 21
The breakthrough relies on custom-designed molecular guides that direct the CRISPR-Cas9 system to identify and cut only the third copy of chromosome 21. By leaving the two healthy chromosomes untouched, the process avoids the widespread genomic damage that previously hindered such attempts. Ryotaro Hashizume, an MDA postdoctoral fellow, led the development of these guides to ensure the system hones in exclusively on the target material. Once the extra chromosome is removed, the cells exhibit restored gene expression patterns consistent with healthy tissue.
Down syndrome, or trisomy 21, occurs in approximately 1 in 700 live births. It remains the most common survivable chromosomal disorder in humans, a reality that has persisted for over fifty years of medical research.
What Happens to Cell Health After Editing?
Removing the extra chromosome triggers immediate improvements in cellular performance. Data from the Mie University team shows that edited cells survived longer and grew at a faster rate than their trisomic counterparts. Furthermore, the cells produced fewer harmful metabolic by-products. These physical changes indicate that mitochondrial function—the engine of the cell—was restored to a near-normal state. This suggests that the presence of the third chromosome is the primary driver of the metabolic dysfunction seen in Down syndrome cells.
What Are the Next Steps for Genetic Therapy?
While the results represent a scientific milestone, the research remains confined to the laboratory. The current priority for the research team is refining the protocol for safety and long-term stability. A significant challenge involves preventing the cell’s natural DNA repair mechanisms from undoing the genetic edits. Researchers are also evaluating how to apply this method to more complex, differentiated tissues beyond the skin and stem cells used in the initial trials.
Comparison: Traditional Research vs. New CRISPR Approaches
| Method | Outcome |
|---|---|
| Previous Gene Therapy | Limited success in gene silencing; no full removal. |
| CRISPR-Cas9 (Mie Univ.) | Full excision of chromosome 21; restored cell health. |
Frequently Asked Questions
Can this method cure Down syndrome in patients?
Not currently. The research is limited to laboratory cell lines. Significant hurdles in safety, delivery, and efficacy must be overcome before any clinical applications could be considered.
Why is removing a full chromosome difficult?
Chromosomes are massive structures. Previous tools lacked the precision required to cut and remove an entire chromosome without damaging the integrity of the remaining DNA.
Is the process permanent?
The research team is still working to ensure that natural DNA repair mechanisms do not reverse the edits, which is a common challenge in gene-editing stability.
Stay updated on the latest breakthroughs in genomic medicine by checking the full PNAS Nexus study to understand the technical specifications of the CRISPR guide design.
What are your thoughts on the future of gene editing? Join the conversation by leaving a comment below, or subscribe to our newsletter for the latest updates on medical science and research.
